BiotechTube
Home/IHP Therapeutics/John Paderi
JP

John Paderi

Chief Scientific Officer

IHP Therapeutics

Therapeutic Areas

HematologyOncology

IHP Therapeutics Pipeline

DrugIndicationPhase
IHP-102Acute vaso-occlusive crisis in sickle cell diseasePre-clinical

Leadership Team at IHP Therapeutics

RG
Rinko Ghosh
President and CEO
GN
Gabriel Njikang
CMC
KS
Kate Stuart
VP of Program Management
View full IHP Therapeutics profile